NeoStem Sees Whopping Jump in Stock Price on $18 Million Backing from California
A graphic depiction of trading on NeoStem stock last week.
Google chart
The stock price of NeoStem, Inc., shot up 28 percent in one day last week after the California stem cell agency approved a nearly $18 million grant to the firm for a potential therapy that “teaches the immune system which cells to attack and kill.”
The governing board of the state rese…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.